目的:分析我国乙肝肝硬化高被引文献的计量特征。方法:检索中国学术期刊全文数据库(CNKI)不限年份的乙肝肝硬化文献,参照普赖斯定律确定高被引文献,用Excel 2007统计分析被引、年份、期刊、作者、单位、关键词、基金。结果:检出高被引文献145篇,累计被引1887次,篇均被引13.01次。文献数自2011年开始曲线上升至2015年达峰值27篇,之后迅速下降;文献分布在97种期刊。文献作者共120人、署名132次,总合作率68.27%;作者机构156个,其中医院占62.82%,5个核心发文机构中院校占60.00%。涉及关键词231个、566次。29篇文献获基金32项次,其中省部级以上基金占53.13%。结论:乙肝肝硬化领域的相关研究仍值得关注,需形成乙肝肝硬化研究的核心团队,加大资助资金。预测未来将围绕乙肝肝硬化患者的管理、干预等方面继续深入地探究。
Objective: To analyze the metrological characteristics of Chinese literature with high citation frequency of hepatitis B cirrhosis. Methods: We searched Chinese Academic Journal FULL-text Database (CNKI) literature on hepatitis B cirrhosis of unlimited years, determined the cited references with high citation frequency by referring to Price’s law, and analyzed the frequency and years of being cited, the cited journals, authors and institutions, keywords, and grants with Excel 2007 statistical analysis. Results: There were 145 cited references with high citation frequency, which were cited 1,887 times in total and mean 13.01 times each. The number of literatures began to rise from 2011 to the peak of 27 articles in 2015, and then fell rapidly. Articles are distributed in 97 different journals. In total, 120 authors signed 132 times, with a total cooperation rate of 68.27%; authors from 156 institutions, including hospitals accounted for 62.82%, and academies and universities accounted for 60.00% of the 5 key institutions. There were 231 keywords and 566 times. Twenty-nine papers received 32 funds, of which 53.13 were funds at or above the provincial and ministerial level. Conclusion: Relevant studies in the field of Hepatitis B cirrhosis are still worthy of attention and a core team for the study of hepatitis B cirrhosis should be formed. The future prediction of increased funding will be further explored in terms of management intervention for patients with hepatitis B cirrhosis.
References
[1]
Ashhab, A.A., Rodin, H., Campos, M., et al. (2020) Response to Hepatitis B Virus Vaccination in Individuals with Chronic Hepatitis C Virus Infection. PLoS ONE, 15, e0237398. https://doi.org/10.1371/journal.pone.0237398
World Health Organization (2017) Global Hepatitis Report 2017. World Health Organization.
https://apps.who.int/iris/handle/10665/255016
[6]
Guan, X., Xing, F. and Li, Y. (2020) Alcohol Consumption Increases the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B Cirrhosis But Not in Patients with Hepatitis C Cirrhosis. European Journal of Gastroenterology & Hepatology, 10, 1097. https://doi.org/10.1097/MEG.0000000000001837
Zhang, T., Yang, Y., Wang, B., et al. (2019) Meta-Analysis of Influences of Biejiajian Pill Combined with Entecavir on Serum Liver Fibrosis Markers of Compensatory Period of Hepatitis B Cirrhosis: Protocol of Systematic Review and Meta-Analysis. Medicine, 98, e18458. https://doi.org/10.1097/MD.0000000000018458